Activation of K2P channel-TREK1 mediates the neuroprotection induced by sevoflurane preconditioning

British Journal of Anaesthesia

Volumn 113, Issue 1, 2014, Pages 157-167

  Tong, L ^a   Cai, M ^a   Huang, Y ^a   Zhang, H ^a   Su, B ^a   Li, Z ^a   Dong, H ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

anaesthetics volatile, sevoflurane; brain, ischaemia; neuroprotection; preconditioning; TREK 1

Indexed keywords

BETA 3 TUBULIN; BETA TUBULIN; CASPASE 3; MESSENGER RNA; NEURON SPECIFIC NUCLEAR PROTEIN; NEUROPROTECTIVE AGENT; POTASSIUM CHANNEL; SEVOFLURANE; TREK 1 PROTEIN; UNCLASSIFIED DRUG;

ANESTHESIA LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; OXYGEN BREATHING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA INTERFERENCE; WESTERN BLOTTING;

ANAESTHETICS VOLATILE, SEVOFLURANE; BRAIN, ISCHAEMIA; NEUROPROTECTION; PRECONDITIONING; TREK-1;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CARBON MONOXIDE; CELL DIFFERENTIATION; CELL HYPOXIA; CELL SURVIVAL; CEREBRAL INFARCTION; GENE KNOCKDOWN TECHNIQUES; HUMANS; ISCHEMIC PRECONDITIONING; MALE; METHYL ETHERS; NEUROPROTECTIVE AGENTS; OXYGEN; PARTIAL PRESSURE; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 84904004508     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aet338     Document Type: Article

References (40)

1. Wechsler LR. Intravenous thrombolytic therapy foracute ischaemic stroke. N Engl J Med 2011; 364: 2138-46
2. Selim M. Perioperative stroke. N Engl J Med 2007; 356: 706-13
3. Kitagawa K, Matsumoto M, Tagaya M, et al. 'Ischemic tolerance' phenomenon found in the brain. Brain Res 1990; 528: 21-4
4. Yang Q, Dong H, Deng J, et al. Sevoflurane preconditioning induces neuroprotection through reactive oxygen species-mediated up-regulation of antioxidant enzymes in rats. Anesth Analg 2011; 112: 931-7
5. Zhao P, Zuo Z. Isoflurane preconditioning induces neuroprotection that is inducible nitric oxide synthase-dependent in neonatal rats. Anesthesiology 2004; 101: 695-703
6. Kapinya KJ, Lowl D, Futterer C, et al. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 2002; 33: 1889-98
7. Fradorf J, Huhn R, Weber NC, et al. Sevoflurane-induced preconditioning: impact of protocol and aprotinin administration on infarct size and endothelial nitric-oxide synthase phosphorylation in the rat heart in vivo. Anesthesiology 2010; 113: 1289-98
8. Codaccioni JL, Velly LJ, Moubarik C, Bruder NJ, Pisano PS, Guillet BA. Sevoflurane preconditioning against focal cerebral ischemia: inhibition of apoptosis in the face of transient improvement of neurological outcome. Anesthesiology 2009; 110: 1271-8
9. Ding Q, Wang Q, Deng J, et al. Sevoflurane preconditioning induces rapid ischemic tolerance against spinal cord ischemia/reperfusion through activation of extracellular signal-regulated kinase in rabbits. Anesth Analg 2009; 109: 1263-72
10. Siegelbaum SA, Camardo JS, Kandel ER. Serotonin and cyclic AMP close single K+ channels in aplysia sensory neurones. Nature 1982; 299: 413-7
11. Mirkovic K, Palmersheim J, Lesage F, Wickman K. Behavioral characterization of mice lacking Trek channels. Front Behav Neurosci 2012; 6: 60
12. Franks NP, Honore E. TheTREKK2Pchannelsandtheir role ingeneral anaesthesia and neuroprotection. Trends Pharmacol Sci 2004; 25: 601-8
13. Heurteaux C, Guy N, Laigle C, et al. TREK-1, a K+ channel involved in neuroprotection and general anesthesia. Embo J 2004; 23: 2684-95
14. Lopes FM, Schroder R, Da FMJ, et al. Comparison between proliferative and neuron-like SH-SY5Ycells as an in vitro model for Parkinson disease studies. Brain Res 2010; 1337: 85-94
15. Cheung YT, Lau WK, Yu MS, et al. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 2009; 30: 127-35
16. Lin D, Feng C, Cao M, Zuo Z. Volatile anestheticsmay not induce significant toxicity to human neuron-like cells. Anesth Analg 2011; 112: 1194-8
17. Bantel C, Maze M, Trapp S. Neuronal preconditioning by inhalational anesthetics: evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology 2009; 110: 986-95
18. Hata R, Mies G, Wiessner C, et al. A reproducible model of middle cerebral artery occlusion in mice: hemodynamic, biochemical, and magnetic resonance imaging. J Cereb Blood Flow Metab 1998; 18: 367-75
19. Wang Q, Gou X, Xiong L, et al. Trans-activator of transcriptionmediated delivery of NEP1-40 protein into brain has a neuroprotective effect against focal cerebral ischemic injury via inhibition of neuronal apoptosis. Anesthesiology 2008; 108: 1071-80
20. Luo J, Wang Y, Chen X, et al. Increased tolerance to ischemic neuronal damage by knockdown of Na+-Ca2+ exchanger isoform 1. Ann N Y Acad Sci 2007; 1099: 292-305
21. Hommel JD, Sears RM, Georgescu D, Simmons DL, DiLeone RJ. Local gene knockdown in the brain using viral-mediated RNA interference. Nat Med 2003; 9: 1539-44
22. Sun J, Tong L, Luan Q, et al. Protective effect of delayed remote limb ischemic postconditioning: role of mitochondrial K(ATP) channelsin a rat model of focal cerebral ischemic reperfusion injury. J Cereb Blood Flow Metab 2012; 32: 851-9
23. Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 1995; 26: 627-34, 635
24. Swanson RA, Sharp FR. Infarct measurement methodology. J Cereb Blood Flow Metab 1994; 14: 697-8
25. Dirnagl U, Becker K, Meisel A. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol 2009; 8: 398-412
26. Liu Y, Xiong L, Chen S, Wang Q. Isoflurane tolerance against focal cerebral ischemia is attenuated by adenosine A1 receptor antagonists. Can J Anaesth 2006; 53: 194-201
27. Sang H, Cao L, Qiu P, Xiong L, Wang R, Yan G. Isoflurane produces delayed preconditioning against spinal cord ischemic injury via release of free radicals in rabbits. Anesthesiology 2006; 105: 953-60
28. Zhang HP, Yuan LB, Zhao RN, et al. Isoflurane preconditioning induces neuroprotection by attenuating ubiquitin-conjugated protein aggregation in a mouse model of transient global cerebral ischemia. Anesth Analg 2010; 111: 506-14
29. Xiong L, Zheng Y, Wu M, et al. Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate- regulated potassium channels after focal cerebral ischemia in rats. Anesth Analg 2003; 96: 233-7
30. Lee MC, Chen CH, Kuo MC, Kang PL, Lo A, Liu K. Isoflurane preconditioning-induced cardio-protection in patients undergoing coronaryartery bypass grafting. Eur J Anaesthesiol 2006; 23: 841-7
31. Kimbro JR, Kelly PJ, Drummond JC, Cole DJ, Patel PM. Isoflurane and pentobarbital reduceAMPAtoxicity in vivoin the rat cerebral cortex. Anesthesiology 2000; 92: 806-12
32. Harada H, Kelly PJ, Cole DJ, Drummond JC, Patel PM. Isoflurane reduces N-methyl-D-aspartate toxicity in vivo in the rat cerebral cortex. Anesth Analg 1999; 89: 1442-7
33. Lin D, Li G, Zuo Z. Volatile anestheticpost-treatmentinduces protection via inhibition of glycogen synthase kinase 3beta in human neuron-like cells. Neuroscience 2011; 179: 73-9
34. Honore E. The neuronal background K2P channels: focus on TREK1. Nat Rev Neurosci 2007; 8: 251-61
35. Blondeau N, Lauritzen I, Widmann C, Lazdunski M, Heurteaux C. A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures. J Cereb Blood Flow Metab 2002; 22: 821-34
36. Namiranian K, Brink CD, Goodman JC, Robertson CS, Bryan RJ. Traumatic brain injury in mice lacking the K channel, TREK-1. J Cereb Blood Flow Metab 2011; 31: e1-6
37. Patel AJ, Honore E, Maingret F, et al. Amammalian twopore domain mechano-gated S-like K+ channel. Embo J 1998; 17: 4283-90
38. Patel AJ, Honore E, Lesage F, Fink M, Romey G, Lazdunski M. Inhalational anesthetics activate two-pore-domain background K+ channels. Nat Neurosci 1999; 2: 422-6
39. Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. Embo J 2000; 19: 1784-93
40. Westphalen RI, Krivitski M, Amarosa A, Guy N, Hemmings HJ. Reduced inhibition of cortical glutamate and GABArelease by halothane in mice lacking the K+ channel, TREK-1. Br J Pharmacol 2007; 152: 939-45